View source for Cycle One particular study of two substantial dosage intensity schedules of the panNotch inhibitor crenigacestat LY3039478 in conjunction with prednisone inside individuals together with sophisticated or even metastatic cancer
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.